Choosing Healthy Carbs
Tian T, Jing J, Li Y, Wang Y, Deng X, Shan Y
How to Get Started: Step-by-Step Step 1: Talk to Your Doctor Bring this article to your appointment Ask: "Do I qualify for the Medicare GLP-1 Bridge program?" Your doctor will check your BMI when you started the medication Your doctor will confirm you meet the health requirements Step 2: Your Doctor Submits Paperwork Your doctor submits a "prior authorization" request to the programs central claims processor This can be done electronically or by fax You don't need to do anything your doctor handles this Submissions accepted starting July 1, 2026 Step 3: Wait for Approval The claims processor will review your doctor's request You'll be notified if you're approved Questions during the wait
Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dualacting medication that targets both GLP1 and glucosedependent insulinotropic polypeptide (GIP) receptors, which may enhance its effects on appetite regulation and metabolism
If you see yourself in any of the 15 concerns we've discussed today, it may be time to explore this groundbreaking path to wellness
The two compounds activate distinct somatotroph receptors (GHRH-R and GHS-R1a), producing additive GH release in published rodent and primate models without the cortisol or prolactin spillover seen with earlier GHRPs, because they couple to different intracellular signalling cascades